Comparison of results of percutaneous coronary interventions in patients with ST-segment elevation myocardial

Grzegorz Słonka1, Mariusz Gasior, Andrzej Lekston

  • 13rd Chair and Department of Cardiology. Silessian Medical University, Siilesian Centre for Heart Diseases, Zabrze, Poland. gslonka@poczta.onet.pl

Kardiologia Polska
|November 6, 2007
PubMed

Insights

Percutaneous coronary interventions (PCI) for ST-segment elevation myocardial infarction (STEMI) yield similar outcomes regardless of whether treatment occurs during the day or off-shift hours. Proper staffing of cardiac catheterization labs ensures comparable results for all STEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Emergency Medicine

Background:

  • Limited data exist on percutaneous coronary interventions (PCI) efficacy for ST-segment elevation myocardial infarction (STEMI) during off-shift hours.
  • Some studies suggest potentially worse outcomes for STEMI patients treated during off-shift periods.

Purpose of the Study:

  • To compare PCI outcomes in STEMI patients admitted during daytime versus off-shift hours.
  • To identify prognostic factors influencing STEMI patient outcomes after PCI.

Main Methods:

  • A retrospective analysis of 1778 STEMI patients undergoing immediate PCI from January 1998 to October 2003.
  • Patients were divided into daytime (n=482) and off-shift (n=1296) groups.
  • Clinical characteristics, procedural data, and outcomes were compared between groups.

Main Results:

  • No significant differences were observed in time to angiography, reocclusion, stroke, haemorrhagic complications, or in-hospital/long-term mortality between daytime and off-shift groups.
  • The rate of stent implantation was slightly higher in the daytime group (71.2% vs. 66.2%, p=0.047).

Conclusions:

  • Around-the-clock onsite staffing of cardiac catheterization laboratories enables comparable PCI results for STEMI patients treated during off-shift hours as during the daytime.
  • Effective organization of cardiology and catheterization laboratory duties is crucial for achieving similar outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...